Orion Pharma

Orion Pharma Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being. Welcome to Orion Pharma page!

On this page, we share information related to Orion Pharma's activities and building well-being. We hope all visitors to the page will behave kindly and respectfully, and honor others' opinions. Please follow the common rules of the page. Inappropriate, offensive, or derogatory messages do not belong in the community spirit, and we reserve the right to remove such comments without warning. Additionally, posts that are unrelated to the topic at hand will be removed. Such messages may include comments made for advertising purposes. As a pharmaceutical company, our communication is guided by laws and regulations related to the pharmaceutical industry, as well as ethical guidelines for pharmaceutical marketing. We cannot provide individual treatment instructions or respond to product inquiries on our social media pages. Instead, we ask you to contact your doctor or pharmacy staff for these matters. We cannot give instructions on the use of prescription drugs or provide advice related to your medication. On this page, we also cannot market prescription products from Orion Pharma or other companies to consumers, so we must remove comments that mention the names of medicinal products. We hope for your understanding in this matter. We reserve the right to moderate discussions. Commenting on posts is possible, but starting new discussion threads is not. We reserve the right to remove comments without warning if:

- They relate to prescription drug products. Marketing prescription drugs to consumers is prohibited by Finnish law. Therefore, we cannot publish the names of products on our pages.
- Comments contain individual treatment instructions or recommendations for the use of medicines, or they relate to the treatment of diseases or the use of medicinal products. We cannot provide individual treatment instructions or recommendations on our page. If you need advice on treating a disease or using medicinal products, please contact your doctor or pharmacy.
- We reserve the right to remove comments at our discretion in cases other than those mentioned above. Adverse Drug Reactions

If you want to report a possible adverse reaction to an Orion Pharma medicinal product, you can make an adverse reaction report to the email address: drugsafety@orionpharma.com, or by calling the number: 010 426 2928. The format of the report is free. For drug safety reasons, Orion Pharma may contact you for additional information. Disclaimer

Orion Corporation is not responsible for the comments made by writers on our wall or for any direct or indirect damages caused by conclusions or actions based on them. There may be links on Orion Corporation's wall to pages maintained by external parties. Orion Corporation is not responsible for the content of pages maintained or published by external parties. Thank you for being part of building Orion Pharma's page and for following our common rules. The page administrator is Orion Corporation.

31/03/2026

Orion Pharma’s subsidiary Fermion operates two API manufacturing sites in Finland – and together they play an important role in European medicine supply.

🏭 In Hanko, active pharmaceutical ingredients are produced in large volumes to meet global demand.

🌍 In Oulu, production focuses on smaller, more specialised batches.

Fermion’s work is a practical reminder that European pharmaceutical manufacturing is an everyday reality – and that patients in Europe and beyond already benefit from it.

Patients are at the heart of everything we do. 💙 Across our focus areas, Orion Pharma’s work is guided by a single commi...
27/03/2026

Patients are at the heart of everything we do. 💙 Across our focus areas, Orion Pharma’s work is guided by a single commitment: to build well-being with Nordic excellence in innovation and healthcare.

We’re proud to say that since 2019, around 200,000 patients with prostate cancer have been treated with the medicine invented by Orion Pharma.

In 2025, our medicines reached people around the world, including:

• 250,000+ people living with Parkinson’s disease,
• over 1.5 million asthma and COPD patients using our inhalers, &
• 500,000+ women going through menopause with HRT.

24/03/2026

Reliable access to medicines starts long before a tablet reaches a patient. 💊

The COVID-19 pandemic demonstrated how vulnerable global supply chains can become when critical production is concentrated outside Europe.

Fermion, Orion Pharma’s subsidiary specialising in active pharmaceutical ingredient manufacturing, operates two production sites in Finland. One of them is located in Oulu – the world’s northernmost API facility – where several ingredients on the European critical medicines list are produced.

As discussions around the EU’s Critical Medicines Act continue, Fermion's work is a reminder that European manufacturing resilience isn't just an objective – it's an everyday reality that patients are already benefiting from.

23/03/2026

“Without trust, there can be no peace.” 🌿

As in peacebuilding, trust is essential to our work as a pharmaceutical company. Patients and healthcare professionals around the world rely on us to provide safe, effective, and dependable medicines and self‑care products.

That trust guides everything we do.

We ensure the quality and efficacy of our products at all stages of their life cycles and remain committed to supporting resilient healthcare systems and maintaining a secure supply of medicines – in all circumstances.

is part of Orion Pharma's collaboration with CMI - Martti Ahtisaari Peace Foundation. Learn more ➡️ https://cmi.fi/about-us/prescriptions-for-peace/

Orion Pharma’s innovative pharmaceutical R&D focuses on oncology and pain, driven by a clear goal: to improve the qualit...
20/03/2026

Orion Pharma’s innovative pharmaceutical R&D focuses on oncology and pain, driven by a clear goal: to improve the quality of life of patients and address unmet medical needs. 🔬

In 2025, we invested more than €210 million in our research and development and opened our new Biologics Research & Development Centre in Cambridge, UK.

The Cambridge centre strengthens our scientific capabilities and supports our innovation driven growth strategy by advancing next generation biological therapies. Located in Europe’s leading biomedical hub, the new site enables collaboration with world-class experts to develop future treatments for patients worldwide. 🌍

Much of Europe’s supply of essential medicines depends on active pharmaceutical ingredient (API) manufacturers outside t...
19/03/2026

Much of Europe’s supply of essential medicines depends on active pharmaceutical ingredient (API) manufacturers outside the EU, leaving supply chains vulnerable. 🌍

Orion Pharma’s subsidiary Fermion shows what stronger European manufacturing resilience can look like in practice. With two API production sites in Finland, Fermion manufactures around thirty active pharmaceutical ingredients, making it one of the leading API producers in the Nordics and a significant global supplier of certain products.

“Thanks to our expertise across research, development and operations, we can keep improving the way we manufacture APIs. Small changes in the process can help us increase production volumes as demand grows”, says Kim Nylund, SVP, Fermion.

One success story is the prostate cancer medicine invented by Orion Pharma, which has already helped around 200,000 patients worldwide. The entire medicine is produced in Finland – the active ingredient by Fermion in Hanko and the finished tablets in Espoo.

Read the full story, link in the comments 👇

Building health is building peace. 🌿That's why we're proud to partner with CMI – Martti Ahtisaari Peace Foundation.Toget...
18/03/2026

Building health is building peace. 🌿

That's why we're proud to partner with CMI – Martti Ahtisaari Peace Foundation.

Together, we're launching Prescriptions for Peace – a video series where CMI's peace mediation experts share what sustainable peace requires.

We believe that well-being isn't just personal. It's about how societies hold together, especially in times of uncertainty.

Read more about our partnership and watch the Prescriptions for Peace videos! 👇

None of our work would be possible without the 4,000 Orionees who build well-being around the world. At Orion Pharma, op...
17/03/2026

None of our work would be possible without the 4,000 Orionees who build well-being around the world. At Orion Pharma, openness, trust, and collaboration are part of our DNA. When our people feel heard, supported, and inspired, they can do work that truly matters. 💎

In 2025, to further strengthen the well-being of our people, we have, for example:

✅ Increased annual short-term incentives globally by 5 million euros to support a high-performance culture and accelerate strategy ex*****on.

✅ Launched the Stellar recognition tool to highlight positive contributions, celebrate everyday successes, and reinforce our shared values. In just three months in 2025, Orionees sent nearly 900 recognition cards to one another!

Discover more People highlights: https://www.orionpharma.com/investors/highlights-2025/

16/03/2026

Did you know that medical research has historically included more men than women in clinical trials? This has created real gaps in our understanding of how certain conditions and treatments affect women.

The good news is that requirements for more inclusive clinical trials are helping to address these knowledge gaps.

Better representation in research means better evidence. And better evidence means better care for every woman.

As a globally operating pharmaceutical company, product availability and patient safety are top priorities for us at Ori...
13/03/2026

As a globally operating pharmaceutical company, product availability and patient safety are top priorities for us at Orion Pharma.

At our sites in Oulu and Hanko, Finland, we produce around 30 active pharmaceutical ingredients. Together with our domestic manufacture of finished medicines, this strengthens the availability of medicines across Europe and beyond.

➡️ Did you know that our Oulu site is the world’s northernmost manufacturer of APIs? ❄️

We remain committed to this work without ever compromising on quality. We follow Good Practices (GxP) across all operations and expect the same from every partner in our value chain. In 2025, we reinforced these standards by conducting 264 GxP audits globally.

12/03/2026

The conversation around menopause is changing. 💬

More women are sharing what this life stage really feels like. Alongside challenges, many also describe growing confidence and freedom.

At Orion Pharma, we have been committed to women’s health for decades. Every woman has the right to live her life to the fullest – today and tomorrow.

Orion Pharma’s global supply chain spans over 50 countries, making responsible sourcing a core part of our sustainabilit...
11/03/2026

Orion Pharma’s global supply chain spans over 50 countries, making responsible sourcing a core part of our sustainability work. 🌍

In 2025, we strengthened the sustainability of our supply chain by:

✅ Conducting 38 on-site sustainability audits to help ensure high standards across our supplier network.

✅ Reaching 96% adherence to our Third Party Code of Conduct (by spend).

✅ Launching a climate engagement programme for our highest emitting suppliers not yet aligned with the Science Based Targets initiative. Through this programme, we share support, best practices, and technical expertise to accelerate climate action together.

Osoite

Orionintie 1 A
Espoo
02200

Puhelin

+358104261

Nettisivu

https://www.orionpharma.com/contact-us/product-related-questions-and-feedback/

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita Orion Pharma :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Ota Yhteyttä Vastaanotto

Lähetä viesti Orion Pharma :lle:

Jaa

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram